COCPCocrystal Pharma, Inc.
1.110USD-1.77%Mkt Cap: 15.17M USDP/E: Last update: 2026-06-01

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-…

Indicators:|

Key Statistics

Company
Market Cap15.17M USD
Enterprise Value12.18M USD
Revenue (TTM)225.00K USD
Gross Profit-4.84M USD
Net Income (TTM)-8.83M USD
Revenue/Share0.0180 USD
Last Price1.110 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS19188J4094
Valuation
P/E (Trailing)
P/E (Forward)-1.75
PEG
EV/EBITDA-1.36
EV/Revenue54.14
P/S68.63
P/B2.44
EPS (TTM)-0.72
EPS (Forward)-0.64
52W Range
0.860014% of range2.670
52W High2.670 USD
52W Low0.8600 USD
Profitability
Gross Margin0.00%
Oper. Margin-1047.11%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-139.49%
ROA-90.93%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-8.19M USD
CapEx (TTM)12.00K USD
FCF Margin-1961.00%
FCF Yield-29.09%
Net Debt-3.26M USD
Net Debt/EBITDA0.36
Balance Sheet
Debt/Equity0.24
Current Ratio2.66
Quick Ratio2.44
Book Value/Sh0.4590 USD
Cash/Share0.3400 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateJan 24, 2018
Splits
Last Split1:12
Split DateOct 11, 2022
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)8.000 USD
Target Range6.000 USD10.00 USD
# Analysts3
Ownership
Shares Out.13.79M
Float9.12M
Insiders25.44%
Institutions5.63%
Short Interest
Short Ratio1.1d
Short % Float2.28%
Short % Out.1.40%
Shares Short192.68K
Short (prev mo.)988.35K
Technical
SMA 501.286 (-13.7%)
SMA 2001.177 (-5.7%)
Beta1.50
S&P 52W Chg27.94%
Avg Vol (30d)132.07K
Avg Vol (10d)124.89K
Technical Indicators
RSI (14)37.5
MACD-0.0568
MACD Signal-0.0427
MACD Hist.-0.0141
BB Upper1.469 USD
BB Middle1.248 USD
BB Lower1.027 USD
BB Width35.43%
ATR (14)0.0852 USD
Vol Ratio (20d)0.65x